Human immunodeficiency virus (HIV) reverse transcriptase activity correlates with HIV RNA load: Implications for resource-limited settings

Journal of Clinical Microbiology

Volumn 43, Issue 8, 2005, Pages 3793-3796

  Sivapalasingam, Sumathi ^a,b   Essajee, Shaffiq ^a   Nyambi, Phillipe N ^a   Itri, Vincenza ^a   Hanna, Bruce ^a   Holzman, Robert ^a   Valentine, Fred ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; RNA DIRECTED DNA POLYMERASE; VIRUS RNA;

ARTICLE; BLOOD LEVEL; CLADISTICS; CLINICAL ARTICLE; CORRELATION COEFFICIENT; ENZYME ACTIVITY; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDUSTRIALIZATION; INTERMETHOD COMPARISON; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UNITED STATES; VIRUS LOAD;

COHORT STUDIES; HIV INFECTIONS; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 23744483412     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.8.3793-3796.2005     Document Type: Article

References (9)

1. Amendola, A., L. Bordi, C. Angeletti, U. Visco-Comandini, I. Abbate, G. Cappiello, M. A. Budabbus, O. A. Eljhawi, M. I. Mehabresh, E. Girardi, A. Antinori, G. Ippolito, and M. R. Capobianchi. 2002. Under-evaluation of HIV-1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV-1 A/G circulating recombinant form (CRF02). J. Acquir. Immun. Defic. Syndr. 31:488-494.
2. Braun, J., J. C. Plantier, M. F. Hellot, E. Tuaillon, M. Gueudin, F. Damond, A. Malmsten, G. E. Corrigan, and F. Simon. 2003. A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes. AIDS 17:331-336.
3. Burda, S., F. A. J. Konings, C. A. U. Williams, C. Anyangwe, and N. P. Nyambi. 2004. HIV-1 CRF09_cpx circulates in the north east province of Cameroon where CRF02_AG infections predominate and recombinant strains are common. AIDS Res. Hum. Retrovir. 20:1358-1363.
4. Erali, M., and D. R. Hillyard. 1999. Evaluation of the ultrasensitive Roche Amplicor HIV-1 monitor assay for quantitation of human immunodeficiency virus type 1 RNA. J. Clin. Microbiol. 37:792-795.
5. Konings, F. A., P. Zhong, M. Agwara, L. Agyingi, L. Zekeng, J. M. Achkar, L. Ewane Saa, E. Afane Ze, T. Kinge, and P. N. Nyambi. 2004. Protease mutations in HIV-1 non-B strains infecting drug-naive villagers in Cameroon. AIDS Res. Hum. Retrovir. 20:105-109.
6. Malmsten, A., X. W. Shao, S. Sjodahl, E. L. Fredriksson, I. Petterson, T. Leitner, C. F. Kallander, E. Sandstorm, and J. S. Gronowitz. 2005. Improved HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma. J. Med. Virol. 76:291-296.
7. Malmsten, A., X. W. Shao, K. Aperia, G. E. Corrigan, E. Sandstrom, C. F. Kallander, T. Leitner, and J. S. Gronowitz. 2003. HIV-1 viral load determination based on reverse transcriptase activity recovered from human plasma. J. Med. Virol. 71:347-359.
8. Mermin, J., R. Downing, G. Anyaegani, A. Malmsten, J. Gronowitz, and G. Corrigan. 2002. Evaluating the Cavidi reverse transcriptase assay to monitor response to antiretroviral therapy, abstr. MoPe3106. Presented at the XIV International AIDS Conference, Barcelona, Spain.
9. Schmitt, Y. 2001. Performance characteristics of quantification assays for human immunodeficiency virus type 1 RNA. J. Clin. Virol. 20:31-33.